GENETIC POLYMORPHISMS IN SLCO1B1 ARE NOT ASSOCIATED WITH ALTERED VOXILAPREVIR EXPOSURE.

被引:0
|
作者
Garrison, K. [1 ]
Song, Q. [1 ]
Stamm, L. [1 ]
Ling, J. [1 ]
Mathias, A. [1 ]
机构
[1] Gilead Sci, Foster City, CA USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PI-073
引用
收藏
页码:S34 / S34
页数:1
相关论文
共 50 条
  • [31] ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population
    Bozina, Tamara
    Ganoci, Lana
    Karacic, Ena
    Simicevic, Livija
    Vrkic-Kirhmajer, Majda
    Klarica-Domjanovic, Iva
    Kriz, Tena
    Sertic, Zrinka
    Bozina, Nada
    ANNALS OF HUMAN BIOLOGY, 2022, 49 (7-8) : 323 - 331
  • [32] Influence of SLCO1B1 polymorphisms on atorvastatin efficacy and safety in Macedonian subjects
    Mladenovska, K.
    Grapci, A. Daka
    Vavlukis, M.
    Kapedanovska, A.
    Eftimovi, A.
    Geshkovska, N. Matevska
    Nebija, D.
    Dimovski, A. J.
    PHARMAZIE, 2017, 72 (05): : 288 - 295
  • [33] The SLCO1B1*5 Genetic Variant Is Associated With Statin-Induced Side Effects
    Voora, Deepak
    Shah, Svati H.
    Spasojevic, Ivan
    Ali, Shazia
    Reed, Carol R.
    Salisbury, Benjamin A.
    Ginsburg, Geoffrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (17) : 1609 - 1616
  • [34] Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure
    Hoa, Pham Quang
    Kim, Hyun Kuk
    Jang, Tae Won
    Seo, Hyewon
    Oh, Jee Youn
    Min, Jinsoo
    Kim, Ho Cheol
    Shin, Ah Young
    Jayanti, Rannissa Puspita
    Hung, Tran Minh
    Anh, Nguyen Ky
    Ahn, Sangzin
    Long, Nguyen Phuoc
    Cho, Yong-Soon
    Shin, Jae-Gook
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)
  • [35] UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?
    de Azevedo, Laura Alencastro
    da Silveire, Themis Reverbel
    Carvalho, Clarissa Gutierrez
    de Castro, Simone Martins
    Giugliani, Roberto
    Matte, Ursula
    PEDIATRIC RESEARCH, 2012, 72 (02) : 169 - 173
  • [38] Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients
    Guo-ping Yang
    Hong Yuan
    Bin Tang
    Wei Zhang
    Lian-sheng Wang
    Zhi-jun Huang
    Dong-sheng Ou-Yang
    Gui-xiang Zhang
    Hong-hao Zhou
    Acta Pharmacologica Sinica, 2010, 31 : 382 - 386
  • [39] Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients
    Yang, Guo-ping
    Yuan, Hong
    Tang, Bin
    Zhang, Wei
    Wang, Lian-sheng
    Huang, Zhi-jun
    Ou-Yang, Dong-sheng
    Zhang, Gui-xiang
    Zhou, Hong-hao
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (03) : 382 - 386
  • [40] EFFECTS OF SLCO1B1 GENETIC POLYMORPHISM ON THE PHARMACOKINETICS OF PITAVASTATIN IN KOREANS
    Choi, C., I
    Bae, J. W.
    Lee, H., I
    Kim, M. J.
    Jang, C. G.
    Lee, S. Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 79 - 79